Table of Contents
What changed
Net revenue rose 71.7% to NZ$7.7m and profit before tax rose 77.1% to NZ$3.3m. Net profit after tax grew 68.4% to NZ$2.3m; the gap to PBT reflects the effective tax rate rising to 32.5% from 29.0%. The balance sheet expanded sharply: total assets +32.2% to NZ$136.1m, equity +79.2% to NZ$24.3m (reflecting a capital raise), and term-deposit funding +24.6% to NZ$109.9m. Cash fell 15.5% to NZ$14.1m, taking net debt from NZ$71.6m to NZ$95.8m, a 33.9% increase. By segment, Finance remained dominant at 81.2% of segment revenue (down from 91.6%) and its segment margin improved to roughly 23.9% from 20.5%; Corporate and Other swung from a NZ$0.3m loss to a NZ$2.1m profit; Research and Advisory deteriorated to a NZ$0.5m loss. No dividend is proposed, consistent with prior year.
What matters
- PBT, not NPAT, is the cleaner growth read. The effective tax rate jumped roughly 3.5 percentage points, trimming 8.7 points from headline NPAT growth. Operationally, PBT growth of 77.1% outpaced revenue growth of 71.7%, pointing to some modest scale benefit in the Finance book.
- Earnings growth did not translate into ROE expansion. Equity grew 79.2% while NPAT grew 68.4%, so ROE eased from 9.9% to 9.3%. The business deployed fresh equity faster than it could earn on it in FY23 — a dilution signal rather than a profitability signal.
- Funding mix is extending leverage. Term deposits rose by roughly NZ$21.8m while cash declined, pushing net debt up about NZ$24.3m. For a deposit-funded finance company this is how growth is supposed to work, but it does tighten the margin for error if loan performance turns.
Expectations
No stated quantitative targets, forward-work backlog, or guidance were disclosed in the extracted material. The only shape context is HY23, which represented 44.8% of FY23 revenue and 46.0% of FY23 NPAT — implying a modestly H2-weighted year but not a dramatic skew. There is no basis in the filing to project FY24, and the release does not support an explicit run-rate claim beyond "growth continued into H2."
Quality of result
The result looks predominantly operational rather than one-off. Finance segment margin expansion and the 77.1% PBT lift are consistent with a larger loan book funded by growing deposits. Two caveats weigh against the durability read. First, the Corporate and Other swing of roughly NZ$2.4m (from a NZ$0.3m loss to a NZ$2.1m profit) is a meaningful contributor to group PBT and the extracted data does not explain what sits inside it — that line, rather than Finance, is the main source of consolidated margin uplift this year. Second, operating cash flow was not extracted, so cash conversion cannot be assessed; the observation that cash fell NZ$2.6m despite NZ$2.3m of NPAT raises a question the filing excerpts do not answer. Capex at NZ$10.5k is immaterial and not a swing factor.
Unresolved
- What drove the Corporate and Other swing from loss to NZ$2.1m profit, and is it repeatable?
- Why did cash decline NZ$2.6m in a year of reported NZ$2.3m NPAT and a capital raise — where did operating and investing cash flows net out?
- What is the Research and Advisory loss trajectory, and is it being funded as a strategic bet or wound down?
- Why did the effective tax rate rise 3.5 points, and is 32.5% the new run-rate?
- What was the size and pricing of the equity raise that lifted equity 79.2%, and what was the implied return threshold on deployed capital?
This briefing cannot assess cash conversion, loan-book credit quality, arrears trends, net interest margin versus peers, or valuation, because operating cash flow, receivables/lending disclosures, NIM, and share/NTA data were not in the extracted material.
Key metrics
| Metric | FY23 | FY22 | Change |
|---|---|---|---|
| Revenue | $7700.3m | $4484.6m | +71.7% ↑ |
| Net profit after tax | $2258.2m | $1340.7m | +68.4% ↑ |
| Profit before tax | $3344.1m | $1888.6m | +77.1% ↑ |
| Cash and cash equivalents | $14072.2m | $16661.6m | -15.5% ↓ |
| Total assets | $136087.9m | $102904.7m | +32.2% ↑ |
Reference: annolyse.ai/briefings/gen-fy23
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Finance | $13583.7m | $7508.9m | $3245.3m | -10.4pp |
| Research and Advisory | $141.5m | $402.7m | −$473.6m | -4.1pp |
| Corporate and Other | $3014.5m | $281.9m | $2109.5m | +14.6pp |
Reference: annolyse.ai/briefings/gen-fy23
Analytical metrics
| Metric | FY23 | FY22 | Context |
|---|---|---|---|
| PBT growth | +77.1% | — | cleaner earnings measure |
| Effective tax rate | 32.5% | 29.0% | — |
| Capex % revenue | 0.1% | 3.5% | — |
| Capex | $10.5m | $155.5m | −$145.0m |
| Net debt | $95813.8m | $71560.0m | +$24253.8m |
| Gross borrowings | $109886.0m | $88221.6m | +$21664.4m |
| ROE (annualised) | 9.3% | 9.9% | Weakening |
| HY23 share of FY23 revenue | 44.8% | — | Other half was 55.2% |
| HY23 share of FY23 NPAT | 46.0% | — | Other half was 54.0% |
| Profit from continuing operations | $2258.2m | — | — |
Reference: annolyse.ai/briefings/gen-fy23
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.